References and publications - Stroke Riskometer

Find references and publications regarding the Stroke Riskometer below:

  1. Feigin, V.L., Owolabi, M.O., on behalf of the World Stroke Organization-Lancet Neurology Commission Stroke Collaboration Group (2023) Pragmatic solutions to reduce the global burden of stroke: A World Stroke Organization - Lancet Neurology Commission. The Lancet Neurology, 22(12), 1160-1206. doi:10.1016/S1474-4422(23)00277-6
  2. Feigin, V. L., Krishnamurthi, R., Medvedev, O., Merkin, A., Nair, B., Kravchenko, M., . . . Hankey, G. (On behalf of the PreventS study team) (2023). Usability and feasibility of PreventS-MD webapp for stroke prevention. International Journal of Stroke, 19(1). doi:10.1177/17474930231190745
  3. Merkin, A., Akinfieva, S., Medvedev, O. N., Krishnamurthi, R. V., Gutsaluk, A., Reips, U. -D., . . . Feigin, V. L. (2023). A pilot study of application of the Stroke Riskometer mobile app for assessment of the course and clinical outcomes of COVID-19 among hospitalised patients. Cerebrovascular Diseases Extra, 13(1), 47-55. doi: 10.1159/000529277
  4. Gall, S., Feigin, V. L., Thrift, A. G., Kleinig, T., Cadilhac, D., Bennett, D., . . . Krishnamurthi, R. (2022). Personalised knowledge to reduce the risk of stroke (PERKS-International): Protocol for a randomised controlled trial. International Journal of Stroke, 18(4). doi: 10.1177/17474930221113430
  5. Feigin, V.L., Krishnamurthi, R. Merkin, A., Nair, B., Kravchenko, M., & Jalili-Moghaddam, S. (2022). Digital solutions for primary stroke and cardiovascular disease prevention: A mass individual and public health approach. The Lancet Regional Health – Western Pacific.
  6. Feigin, V.L., Owolabi, M., Hankey, G.J., Pandian, J.D., & Martins, S.C. (2022). Digital health in primordial and primary stroke prevention: a systematic review. Stroke, 53, 1008-1019.
  7. Medvedev, O., Truong, Q., Merkin, A., Borotkanics, R., Krishnamurthi, R., & Feigin, V. (2021). Cross-cultural validation of the Stroke Riskometer using generalizability theory. Scientific Reports, 11(1), 19064.
  8. Mat Zaid, Z., Musa, K.I., Ismail, T.A.T., Hamid, A.A., Sahathevan, R., Aziz, Z.A. & Feigin, V.L. (2021). The effectiveness of Stroke Riskometer in improving stroke risk awareness in Malaysia: A study protocol of a cluster-randomized controlled trial. Neuroepidemiology, 55, 436-446.doi:
  9. Feigin, V. L., Brainin, M., Norrving, B., Gorelick, P. B., Dichgans, M., Wang, W., . . . Hankey, G. J. (2020). What is the best mix of population‐wide and high‐risk targeted strategies of primary stroke and cardiovascular disease prevention?. Journal of the American Heart Association, 9(3). doi:10.1161/jaha.119.014494
  10. Brainin, M., Feigin, V., Norrving, B., Martins, S., Hankey, G. J., & Hachinski, V. (2020). Global prevention of stroke and dementia: The WSO Declaration. The Lancet Neurology, 19(6), 487-488. doi:10.1016/S1474-4422(20)30141-1
  11. Brainin, M., Feigin, V., Norrving, B., Martins, S. C. O., Hachinski, G. J., & Hankey, G. J. (2020). Russian translation of [Global prevention of stroke and dementia: The WSO Declaration]. Annals of Clinical and Experimental Neurology, 14(3), 5-10. doi:10.25692/ACEN.2020.3.1
  12. Krishnamurthi, R., George, A., Merkin, A., Bhattacharjee, R., & Feigin, V. L. (2020). Can we stop the stroke tsunami? Mitigating the barriers, amplifying the facilitators. Journal of the Royal Society of New Zealand. doi:10.1080/03036758.2020.1798477
  13. Martins, S. C., Sacks, C., Werner, H., & Feigin, V. (2019). Priorities to reduce the burden of stroke in Latin American countries. The Lancet Neurology, 18(7), 674-683. doi:10.1016/S1474-4422(19)30068-7
  14. Brainin, M., Feigin, V., Bath, P. M., Collantes, E., Martins, S., Pandian, J., . . . Teuschl, Y. (2019). Multi-level community interventions for primary stroke prevention: A conceptual approach by the World Stroke Organization. International Journal of Stroke, 14(8), 818-825. doi:10.1177/1747493019873706
  15. Feigin, V. (2019). Anthology of stroke epidemiology in the 20th and 21st centuries: Assessing the past, the present, and envisioning the future. International Journal of Stroke, 14(3), 223-237. doi:10.1177/1747493019832996
  16. Feigin, V., & Brainin, M. (2019). Reducing the burden of stroke: Opportunities and mechanisms. International Journal of Stroke, 14(8), 761-762. doi:10.1177/1747493019874718
  17. Krishnamurthi, R., Hale, L., Barker-Collo, S., Theadom, A., Bhattacharjee, R., George, A., Parmar, P., . . . Feigin, V. (2018). Mobile technology for primary stroke prevention. Stroke, 50, 196-198
  18. Bhattacharjee, R., & Hussein, T. (2018). Digital data (mHealth and social media). In R. Vasan & D. Sawyer (Eds.). The Encyclopedia of cardiovascular research and medicine, vol. 2. (pp. 90-91). Oxford, UK; Elsevier.
  19. Brainin, M., Feigin, V., Martins, S., Matz, K., Roy, J., Sandercock, P., . . . Wiseman, A. (2018). Cut stroke in half: Polypill for primary prevention in stroke. International Journal of Stroke, 13(6). doi:10.1177/1747493018761190
  20. Krishnamurthi R, Bhattacharjee R, Parmar P, et. al. (2018). Effectiveness of the Stroke Riskometer app for primary stroke prevention: A pilot RCT. Late-Breaking News Science Abstracts of the 2018 International Stroke Conference, Los Angeles, USA. Presentation Number LBP18, page 85.
  21. Feigin VL, Norrving B, Mensah GA. (2017). Primary prevention of cardiovascular disease through population-wide motivational strategies: Insights from using smartphones in stroke prevention. BMJ Global Health, 2(2). doi: 10.1136/bmjgh-2017-000306.
  22. Feigin VL. (2017). Primary stroke prevention needs overhaul. International Journal of stroke, 12(1), 5-6. doi: 10.1177/1747493016669850.
  23. Béjot, Y., Giroud, M., & Feigin, V. L. (2017). French version of the Stroke Riskometer™ App: A new tool to reduce the burden of stroke. In Revue Neurologique (Iss. 4). Elsevier Masson. doi:10.1016/j.neurol.2017.01.399
  24. Feigin VL, Varakin YY, Kravchenko MA, et. al. (2016). A new approach to stroke prevention in Russia. Human Physiology, 42(8), 854-57. doi: 10.1134/s0362119716080053.
  25. O'Donnell MJ, Chin SL, Rangarajan S, et. al. (2016). Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. The Lancet, 388(10046), 761-75. doi: 10.1016/s0140-6736(16)30506-2.
  26. Feigin VL, Norrving B, George MG, Foltz JL, Roth GA, Mensah GA. (2016). Prevention of stroke: A strategic global imperative. Nature Reviews Neurology, 12(9), 501-512. doi: 10.1038/nrneurol.2016.107.
  27. Feigin, V., & Krishnamurthi, R. (2016). Stroke is largely preventable across the globe: Where to next? [comment].The Lancet, 10046. doi:10.1016/S0140-6736(16)39679-1
  28. Morgan, J. (21016). The power of the app: Can mobile technology save lives? The Lancet Neurology, 15(7), 668. doi:
  29. Feigin VL, Wang W, Fu H, et. al. (2015). Primary stroke prevention in China - a new approach. Neurological Research, 37(5), 378-380. doi: 10.1179/1743132815Y.0000000025.
  30. Parmar P, Krishnamurthi R, Ikram MA, et. al. (2015). The Stroke Riskometer(TM) App: Validation of a data collection tool and stroke risk predictor. International Journal of Stroke, 10(2), 231-44 doi: 10.1111/ijs.12411.
  31. Feigjn, V.L., Krishnamurthi, R., & Bhattacharjee, R. (2015). Putting your health in your own hands: A new strategy for primary stroke prevention. In Global Summit on Stroke, Birmingham, UK, August 3-5, 2015. In Brain Disorders & Therapy, 4(4), p. 88.
  32. Bhattacharjee, R., Krishnamurthi, R., Hussein, T., & Purohit, M. (2015). the Stroke Riskometer: A new tool to measure and monitor stroke risk. In  2015 Stroke Conference, Melbourne, Australia, September 2-4. In International Journal of Stroke, 10(S3), 52-84.
  33. Feigin VL, Krishnamurthi R, Bhattacharjee R, et. al. (2015). New strategy to reduce the global burden of stroke. Stroke, 46(6), 1740-1747. doi: 10.1161/STROKEAHA.115.008222.
  34. Norrving, B., Davis, S. M., Feigin, V. L., Mensah, G. A., Sacco, R. L., & Varghese, C. (2015). Stroke prevention worldwide - What could make it work. Neuroepidemology, 45(3). doi:10.1159/000441104
  35. Feigin, V., Varakin, Y. Y., Kravchenko, M. A., Piradov, M. A., Tanashayan, M. M., Gnedovskaya, E. V., . . . Barker-Collo, S. (2015). A new approach for stroke prevention in Russia. Annaly-Nevrologii, 9(4). Retrieved from
  36. Feigin, V.L., Norrving, B., & Wiebers, D. (2015). Approaches to prevention of cardiovascular disease [comment]. JAMA - Journal of the American Medical Association, 314(21), 2306.
  37. Brindle P, Emberson J, Lampe F, et. al. (2003). Predictive accuracy of the Framingham coronary risk score in British men: Prospective cohort study. British Medical Journal, 327(7426), 1267-1270.
  38. Feigin VL, Norrving B. (2014). A new paradigm for primary prevention strategy in people with elevated risk of stroke. International Journal of Stroke, 9(5), 624-626. doi: 10.1111/ijs.12300.
  39. D'Agostino. (2008). General cardiovascular risk profile for use in primary care: The Framingham heart study. Circulation, 117, 743-753. doi: 10.1161/CIRCULATIONAHA.107.699579.
  40. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. (1994). Stroke risk profile: Adjustment for antihypertensive medication. The Framingham Study. Stroke, 25(1), 40-43.